Skip to main content

Nasopharynx and Skull Base

  • Chapter
  • First Online:
  • 1252 Accesses

Abstract

How many times have the terms “sinonasal” and “nasopharyngeal” been incorrectly interchanged on requisition sheets? This chapter offers more examples that emphasize the importance of anatomic and clinicoradiographic correlation in arriving at a correct diagnosis. A “hairy polyp” may appear quite unimpressive until you realize it’s not a dermal lesion. A biopsy from an ectopic pituitary adenoma or macroadenoma may lead you down the incorrect path of sinonasal neuroendocrine carcinoma, a biopsy from a craniopharyngioma may have you thinking about an ameloblastoma, an ecchordosis physaliphora can mimic chordoma. In this cost conscious era where pathologists need be more time efficient, and use fewer immunohistochemical resources, less anatomic and clinical information is not an option.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Babić MS. Relationship between notochord and the bursa pharyngea in early human development. Cell Differ Dev. 1990;32:125–30.

    Article  PubMed  Google Scholar 

  2. Ikushima I, Korogi Y, Makita O, Komohara Y, Kawano H, Yamura M, Arikawa K, Takahashi M. MR imaging of Tornwaldt’s cysts. AJR Am J Roentgenol. 1999;172:1663–5.

    Article  CAS  PubMed  Google Scholar 

  3. Ali MY. Histology of the human nasopharyngeal mucosa. J Anat. 1965;99:657–72.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Marom T, Russo E, Ben Salem D, Roth Y. Nasopharyngeal cysts. Int J Pediatr Otorhinolaryngol. 2009;73:1063–70.

    Article  PubMed  Google Scholar 

  5. Heller D, Brandwein M, Klein M, Biller H. Hairy polyp. Am J Rhinol. 1989;3:5–8.

    Article  Google Scholar 

  6. Ibrahim N, Wooles NR, Elloy M, Da Forno P. A hairy situation. BMJ Case Rep. 2015;2015. pii: bcr2015209825. doi:10.1136/bcr-2015-209825.

    Google Scholar 

  7. Dutta M, Roy S, Ghatak S. Nasopharyngeal choristoma (hairy polyps) an overview and current update on presentation, management, origin and related controversies. Eur Arch Otorhinolaryngol. 2015;272:1047–59.

    Article  PubMed  Google Scholar 

  8. Manica D, Neto CS, Schweiger C, Cortina M, Kuhl G. Dermoid of the nasopharynx causing neonatal respiratory distress. Int Arch Otorhinolaryngol. 2013;17:407–8.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Maeda Y, Suenaga H, Sugiyama M, Saijo H, Hoshi K, Mori Y, Takato T. Clinical presentation of epignathus teratoma with cleft palate; and duplication of cranial base, tongue, mandible, and pituitary gland. J Craniofac Surg. 2013;24:1486–91.

    Article  PubMed  Google Scholar 

  10. Parajuli R, Thapa S, Maharjan S. Mature nasopharyngeal teratoma in a child. Case Rep Otolaryngol. 2015;2015:515474. doi:10.1155/2015/515474.

    PubMed  PubMed Central  Google Scholar 

  11. Tariq MU, Din NU, Bashir MR. Hairy polyp, a clinicopathologic study of four cases. Head Neck Pathol. 2013;7:232–5.

    Article  PubMed  PubMed Central  Google Scholar 

  12. He J, Wang Y, Zhu H, Qiu W, He Y. Nasopharyngeal teratoma associated with cleft palate in newborn: report of 2 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109:211–6.

    Article  PubMed  Google Scholar 

  13. Olivares-Pakzad BA, Tazelaar HD, Dehner LP, Kasperbauer JL, Bite U. Oropharyngeal hairy polyp with meningothelial elements. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79:462–8.

    Article  CAS  PubMed  Google Scholar 

  14. Hossein A, Mohammad A. Huge teratoma of the nasopharynx. Am J Otolaryngol. 2007;28:177–9.

    Article  PubMed  Google Scholar 

  15. Ozturk A, Gunay GK, Akin MA, Arslan F, Tekelioglu F, Coban D. Multiple intraoral teratoma in a newborn infant: epignathus. Fetal Pediatr Pathol. 2012;31:210–6.

    Article  PubMed  Google Scholar 

  16. Maartens IA, Wassenberg T, Halbertsma FJ, Marres HA, Andriessen P. Neonatal airway obstruction caused by rapidly growing nasopharyngeal teratoma. Acta Paediatr. 2009;98:1852–4.

    Article  CAS  PubMed  Google Scholar 

  17. Sreetharan SS, Prepageran N. Benign teratoma of the nasal cavity. Med J Malaysia. 2004;59:678–9.

    CAS  PubMed  Google Scholar 

  18. Saha SP, Hobson E, Joss S. Nasopharyngeal teratoma associated with a complex congenital cardiac anomaly. Clin Dysmorphol. 2007;16:113–4.

    Article  PubMed  Google Scholar 

  19. Lim CM, Ho CS, Pang KP, Ng SB, Goh HK. Nasopharyngeal teratoma in an adult. Ear Nose Throat J. 2005;84:550–1.

    PubMed  Google Scholar 

  20. Ulger Z, Egemen A, Karapinar B, Veral A, Apaydin F. A very rare cause of recurrent apnea: congenital nasopharyngeal teratoma. Turk J Pediatr. 2005;47:266–9.

    PubMed  Google Scholar 

  21. Andrews JC, Fisch U, Valavanis A, Aeppli U, Makek MS. The surgical management of extensive nasopharyngeal angiofibromas with the infratemporal fossa approach. Laryngoscope. 1989;99:429–37.

    Article  CAS  PubMed  Google Scholar 

  22. Snyderman CH, Pant H, Carrau RL, Gardner P. A new endoscopic staging system for angiofibromas. Arch Otolaryngol Head Neck Surg. 2010;136:588–94.

    Article  PubMed  Google Scholar 

  23. López F, Suárez V, Costales M, Suárez C, Llorente JL. Treatment of juvenile angiofibromas: 18-year experience of a single tertiary centre in Spain. Rhinology. 2012;50:95–103.

    PubMed  Google Scholar 

  24. Chan KH, Gao D, Fernandez PG, Kingdom TT, Kumpe DA. Juvenile nasopharyngeal angiofibroma: vascular determinates for operative complications and tumor recurrence. Laryngoscope. 2014;124:672–7.

    Article  PubMed  Google Scholar 

  25. Fyrmpas G, Konstantinidis I, Constantinidis J. Endoscopic treatment of juvenile nasopharyngeal angiofibromas: our experience and review of the literature. Eur Arch Otorhinolaryngol. 2012;269:523–9.

    Article  CAS  PubMed  Google Scholar 

  26. Mattei TA, Nogueira GF, Ramina R. Juvenile nasopharyngeal angiofibroma with intracranial extension. Otolaryngol Head Neck Surg. 2011;145:498–504.

    Article  PubMed  Google Scholar 

  27. Boghani Z, Husain Q, Kanumuri VV, Khan MN, Sangvhi S, Liu JK, Eloy JA. Juvenile nasopharyngeal angiofibroma: a systematic review and comparison of endoscopic, endoscopic-assisted, and open resection in 1047 cases. Laryngoscope. 2013;123:859–69.

    Article  PubMed  Google Scholar 

  28. Perić A, Sotirović J, Cerović S, Zivić L. Immunohistochemistry in diagnosis of extranasopharyngeal angiofibroma originating from nasal cavity: case presentation and review of the literature. Acta Medica (Hradec Kralove). 2013;56(4):133–41.

    Article  Google Scholar 

  29. Salimov A, Ozer S. A rare location of angiofibroma in the inferior turbinate in young woman. Int Arch Otorhinolaryngol. 2015;19(2):187–90.

    PubMed  Google Scholar 

  30. Perić A, Baletić N, Cerović S, Vukomanović-Durdević B. Middle turbinate angiofibroma in an elderly woman. Vojnosanit Pregl. 2009;66(7):583–6.

    Article  PubMed  Google Scholar 

  31. Szymańska A, Korobowicz E, Gołabek W. A rare case of nasopharyngeal angiofibroma in an elderly female. Eur Arch Otorhinolaryngol. 2006;263:657–60.

    Article  PubMed  Google Scholar 

  32. Mohindra S, Grover G, Bal AK. Extranasopharyngeal angiofibroma of the nasal septum: a case report. Ear Nose Throat J. 2009;88:E17–9.

    PubMed  Google Scholar 

  33. Patrocínio JA, Patrocínio LG, Borba BH, Bonatti Bde S, Guimarães AH. Nasopharyngeal angiofibroma in an elderly woman. Am J Otolaryngol. 2005;26:198–200.

    Article  PubMed  Google Scholar 

  34. Akbas Y, Anadolu Y. Extranasopharyngeal angiofibroma of the head and neck in women. Am J Otolaryngol. 2003;24:413–6.

    Article  PubMed  Google Scholar 

  35. Windfuhr JP, Remmert S. Extranasopharyngeal angiofibroma: etiology, incidence and management. Acta Otolaryngol. 2004;124:880–9.

    Article  CAS  PubMed  Google Scholar 

  36. Szymańska A, Szymański M, Czekajska-Chehab E, Szczerbo-Trojanowska M. Invasive growth patterns of juvenile nasopharyngeal angiofibroma: radiological imaging and clinical implications. Acta Radiol. 2014;55:725–31.

    Article  PubMed  Google Scholar 

  37. Chakraborty S, Ghoshal S, Patil VM, Oinam AS, Sharma SC. Conformal radiotherapy in the treatment of advanced juvenile nasopharyngeal angiofibroma with intracranial extension: an institutional experience. Int J Radiat Oncol Biol Phys. 2011;80:1398–404.

    Article  PubMed  Google Scholar 

  38. Donald PJ. Sarcomatous degeneration in a nasopharyngeal angiofibroma. Otolaryngol Head Neck Surg. 1979;87:42–6.

    Article  CAS  PubMed  Google Scholar 

  39. Makek MS, Andrews JC, Fisch U. Malignant transformation of a nasopharyngeal angiofibroma. Laryngoscope. 1989;99:1088–92.

    Article  CAS  PubMed  Google Scholar 

  40. Spagnolo DV, Papadimitriou JM, Archer M. Postirradiation malignant fibrous histiocytoma arising in juvenile nasopharyngeal angiofibroma and producing alpha-1-antitrypsin. Histopathology. 1984;8:339–52.

    Article  CAS  PubMed  Google Scholar 

  41. Schick B, Rippel C, Brunner C, Jung V, Plinkert PK, Urbschat S. Numerical sex chromosome aberrations in juvenile angiofibromas: genetic evidence for an androgen-dependent tumor? Oncol Rep. 2003;10:1251–5.

    CAS  PubMed  Google Scholar 

  42. Abraham SC, Montgomery EA, Giardiello FM, Wu TT. Frequent beta-catenin mutations in juvenile nasopharyngeal angiofibromas. Am J Pathol. 2001;158:1073–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Ponti G, Losi L, Pellacani G, Rossi GB, Presutti L, Mattioli F, Villari D, Wannesson L, Alicandri Ciufelli M, Izzo P, De Rosa M, Marone P, Seidenari S. Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA). Appl Immunohistochem Mol Morphol. 2008;16:173–8.

    Article  CAS  PubMed  Google Scholar 

  44. Silveira SM, Custódio Domingues MA, Butugan O, Brentani MM, Rogatto SR. Tumor microenvironmental genomic alterations in juvenile nasopharyngeal angiofibroma. Head Neck. 2012;34:485–92.

    Article  PubMed  Google Scholar 

  45. Montag AG, Tretiakova M, Richardson M. Steroid hormone receptor expression in nasopharyngeal angiofibromas. Consistent expression of estrogen receptor beta. Am J Clin Pathol. 2006;125:832–7.

    Article  CAS  PubMed  Google Scholar 

  46. Liu Z, Wang J, Wang H, Wang D, Hu L, Liu Q, Sun X. Hormonal receptors and vascular endothelial growth factor in juvenile nasopharyngeal angiofibroma: immunohistochemical and tissue microarray analysis. Acta Otolaryngol. 2015;135:51–7.

    Article  CAS  PubMed  Google Scholar 

  47. Giardiello FM, Hamilton SR, Krush AJ, Offerhaus JA, Booker SV, Petersen GM. Nasopharyngeal angiofibroma in patients with familial adenomatous polyposis. Gastroenterology. 1993;105:1550–2.

    Article  CAS  PubMed  Google Scholar 

  48. Ferouz AS, Mohr RM, Paul P. Juvenile nasopharyngeal angiofibroma and familial adenomatous polyposis: an association? Otolaryngol Head Neck Surg. 1995;113:435–9.

    Article  CAS  PubMed  Google Scholar 

  49. Klockars T, Renkonen S, Leivo I, Hagström J, Mäkitie AA. Juvenile nasopharyngeal angiofibroma: no evidence for inheritance or association with familial adenomatous polyposis. Fam Cancer. 2010;9:401–3.

    Article  PubMed  Google Scholar 

  50. Valanzano R, Curia MC, Aceto G, Veschi S, De Lellis L, Catalano T, La Rocca G, Battista P, Cama A, Tonelli F, Mariani-Costantini R. Genetic evidence that juvenile nasopharyngeal angiofibroma is an integral FAP tumour. Gut. 2005;54:1046–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Guo G, Paulino AFG. Lipomatous variant of nasopharyngeal angiofibroma. A case report. Arch Otolaryngol Head Neck Surg. 2002;128:448–50.

    Article  PubMed  Google Scholar 

  52. Dehner LP, Valbuena L, Perez-Atayde A, et al. Salivary gland anlage tumor (“congenital pleomorphic adenoma”). a clinicopathologic, immunohistochemical and ultrastructural study of nine cases. Am J Surg Pathol. 1994;18:25–36.

    Article  CAS  PubMed  Google Scholar 

  53. Har-El G, Zirkin HY, Tovi F, Sidi J. Congenital pleomorphic adenoma of the nasopharynx (report of a case). J Laryngol Otol. 1985;99:1281–7.

    Article  CAS  PubMed  Google Scholar 

  54. Boccon-Gibod LA, Grangeponte MC, Boucheron S, Josset PP, Roger G, Berthier-Falissard ML. Salivary gland anlage tumor of the nasopharynx: a clinicopathologic and immunohistochemical study of three cases. Pediatr Pathol Lab Med. 1996;16:973–83.

    Article  CAS  PubMed  Google Scholar 

  55. Cohen EG, Yoder M, Thomas RM, Salerno D, Isaacson G. Congenital salivary gland anlage tumor of the nasopharynx. Pediatrics. 2003;112:e66–9.

    Article  PubMed  Google Scholar 

  56. Herrman BW, Dehner LP, Lieu JEC. Congenital salivary gland anlage tumor: a case report and review of the literature. Int J Ped Otorhinnolaryngl. 2005;69:149–56.

    Article  Google Scholar 

  57. Mogensen MA, Lin AC, Chang KW, Berry GJ, Barnes PD, Fischbein NJ. Salivary gland anlage tumor in a neonate presenting with respiratory distress: radiographic and pathologic correlation. Am J Neuroradiol. 2009;30:1022–3.

    Article  CAS  PubMed  Google Scholar 

  58. Tinsa F, Boussetta K, Bousnina S, Menif K, Nouira F, Haouet S, Sahtout S. Congenital salivary gland anlage tumor of the nasopharynx. Fetal Pediatr Pathol. 2010;29:323–9.

    Article  PubMed  Google Scholar 

  59. Gauchotte G, Coffinet L, Schmitt E, Bressenot A, Hennequin V, Champigneulle J, Vignaud JM. Salivary gland anlage tumor: a clinicopathological study of two cases. Fetal Pediatr Pathol. 2011;30:116–23.

    Article  PubMed  Google Scholar 

  60. Marien A, Maris M, Verbeke S, Creytens D, Verlooy J, Van Reempts P, Boudewyns A. An unusual tumour causing neonatal respiratory distress. B-ENT. 2012;8:149–51.

    CAS  PubMed  Google Scholar 

  61. Stamm AC, Vellutini E, Balsalobre L. Craniopharyngioma. Otolaryngol Clin North Am. 2011;44:937–52.

    Article  PubMed  Google Scholar 

  62. Martinez-Barbera JP. 60 years of neuroendocrinology: biology of human craniopharyngioma: lessons from mouse models. J Endocrinol. 2015;226:T161–72.

    Article  CAS  PubMed  Google Scholar 

  63. Kostadinov S, Hanley CL, Lertsburapa T, O’Brien B, He M. Fetal craniopharyngioma: management, postmortem diagnosis, and literature review of an intracranial tumor detected in utero. Pediatr Dev Pathol. 2014;17:409–12.

    Article  PubMed  Google Scholar 

  64. Wang KC, Hong SH, Kim SK, Cho BK. Origin of craniopharyngiomas: implication on the growth pattern. Childs Nerv Syst. 2005;21:628–34.

    Article  PubMed  Google Scholar 

  65. Alomari AK, Kelley BJ, Damisah E, Marks A, Hui P, DiLuna M, Vortmeyer A. Craniopharyngioma arising in a Rathke’s cleft cyst: case report. J Neurosurg Pediatr. 2015;15:250–4.

    Article  PubMed  Google Scholar 

  66. Fernandez-Miranda JC, Gardner PA, Snyderman CH, Devaney KO, Strojan P, Suárez C, Genden EM, Rinaldo A, Ferlito A. Craniopharyngioma: a pathologic, clinical, and surgical review. Head Neck. 2012;34:1036–44.

    Article  PubMed  Google Scholar 

  67. Larkin SJ, Ansorge O. Pathology and pathogenesis of craniopharyngiomas. Pituitary. 2013;16:9–17.

    Article  PubMed  Google Scholar 

  68. Larkin SJ, Preda V, Karavitaki N, Grossman A, Ansorge O. BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma. Acta Neuropathol. 2014;127:927–9.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Rosenfeld A, Arrington D, Miller J, Olson M, Gieseking A, Etzl M, Harel B, Schembri A, Kaplan A. A review of childhood and adolescent craniopharyngiomas with particular attention to hypothalamic obesity. Pediatr Neurol. 2014;50:4–10.

    Article  PubMed  Google Scholar 

  70. Šteňo J, Bízik I, Šteňo A, Matejčík V. Recurrent craniopharyngiomas in children and adults: long-term recurrence rate and management. Acta Neurochir. 2014;156:113–22.

    Article  PubMed  Google Scholar 

  71. Koutourousiou M, Gardner PA, Fernandez-Miranda JC, Tyler-Kabara EC, Wang EW, Snyderman CH. Endoscopic endonasal surgery for craniopharyngiomas: surgical outcome in 64 patients. J Neurosurg. 2013;119:1194–207.

    Article  PubMed  Google Scholar 

  72. Winkfield KM, Tsai HK, Yao X, Larson E, Neuberg D, Pomeroy SL, Ullrich NJ, Cohen LE, Kieran MW, Scott RM, Goumnerova LC, Marcus KJ. Long-term clinical outcomes following treatment of childhood craniopharyngioma. Pediatr Blood Cancer. 2011;56:1120–6.

    Article  PubMed  Google Scholar 

  73. Mortini P, Losa M, Pozzobon G, Barzaghi R, Riva M, Acerno S, Angius D, Weber G, Chiumello G, Giovanelli M. Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series. J Neurosurg. 2011;114:1350–9.

    PubMed  Google Scholar 

  74. Okada T, Fujitsu K, Ichikawa T, Mukaihara S, Miyahara K, Kaku S, Uryuu Y, Niino H, Yagishita S, Shiina T. Coexistence of adamantinomatous and squamous-papillary type craniopharyngioma: case report and discussion of etiology and pathology. Neuropathology. 2012;32:171–3.

    Article  PubMed  Google Scholar 

  75. Wang W, Chen XD, Bai HM, Liao QL, Dai XJ, Peng DY, Cao HX. Malignant transformation of craniopharyngioma with detailed follow-up. Neuropathology. 2015;35:50–5.

    Article  CAS  PubMed  Google Scholar 

  76. Thompson LD, Seethala RR, Müller S. Ectopic sphenoid sinus pituitary adenoma ESSPA) with normal anterior pituitary gland: a clinicopathologic and immunophenotypic study of 32 cases with a comprehensive review of the English literature. Head Neck Pathol. 2012;6:75–100.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Johnston PC, Kennedy L, Weil RJ, Hamrahian AH. Ectopic ACTH-secreting pituitary adenomas within the sphenoid sinus. Endocrine. 2014;47:717–24.

    Article  CAS  PubMed  Google Scholar 

  78. Ali R, Noma U, Jansen M, Smyth D. Ectopic pituitary adenoma presenting as a midline nasopharyngeal mass. Ir J Med Sci. 2010;179:593–5.

    Article  CAS  PubMed  Google Scholar 

  79. Silva Junior NA, Reis F, Miura LK, Vieira GH, Queiroz LS, Garmes HM, Benetti-Pinto CL. Pituitary macroadenoma presenting as a nasal tumor: case report. Sao Paulo Med J. 2014;132:377–81.

    Article  PubMed  Google Scholar 

  80. Öngürü Ö, Düz B, Şimşek H, Günal A, Gönül E. Pituitary macroadenomas (>3 cm) in young adulthood: pathologic and proliferative characteristics. Neurol Neurochir Pol. 2015;49:212–6.

    PubMed  Google Scholar 

  81. Ravichandran TP, Bakshi R, Heffner RR, Gibbons KJ, Bates VE, Durante DJ, Kinkel WR. Aggressive giant pituitary adenoma presenting as a nasopharyngeal mass: magnetic resonance imaging and pathologic findings. J Neurooncol. 1999;41:71–5.

    Article  CAS  PubMed  Google Scholar 

  82. Walcott BP, Nahed BV, Mohyeldin A, Coumans JV, Kahle KT, Ferreira MJ. Chordoma: current concepts, management, and future directions. Lancet Oncol. 2012;13:e69–76.

    Article  PubMed  Google Scholar 

  83. Fernandez-Miranda JC, Gardner PA, Snyderman CH, Devaney KO, Mendenhall WM, Suárez C, Rinaldo A, Ferlito A. Clival chordomas: a pathological, surgical, andradiotherapeutic review. Head Neck. 2014;36:892–906.

    Article  PubMed  Google Scholar 

  84. Jones PS, Aghi MK, Muzikansky A, Shih HA, Barker 2nd FG, Curry Jr WT. Outcomes and patterns of care in adult skull base chordomas from the surveillance, epidemiology, and End results (SEER) database. J Clin Neurosci. 2014;21:1490–6.

    Article  PubMed  Google Scholar 

  85. Ridenour 3rd RV, Ahrens WA, Folpe AL, Miller DV. Clinical and histopathologic features of chordomas in children and young adults. Pediatr Dev Pathol. 2010;13:9–17.

    Article  PubMed  Google Scholar 

  86. Wang KE, Wu Z, Tian K, Wang L, Hao S, Zhang L, Zhang J. Familial chordoma: a case report and review of the literature. Oncol Lett. 2015;10:2937–40.

    PubMed  PubMed Central  Google Scholar 

  87. Kelley MJ, Shi J, Ballew B, Hyland PL, Li WQ, Rotunno M, Alcorta DA, Liebsch NJ, Mitchell J, Bass S, Roberson D, Boland J, Cullen M, He J, Burdette L, Yeager M, Chanock SJ, Parry DM, Goldstein AM, Yang XR. Characterization of T gene sequence variants and germline duplications in familial and sporadic chordoma. Hum Genet. 2014;133:1289–97.

    Article  CAS  PubMed  Google Scholar 

  88. Miettinen M, Wang Z, Lasota J, Heery C, Schlom J, Palena C. Nuclear brachyury expression is consistent in chordoma, common in germ cell tumors and small cell carcinomas, and rare in other carcinomas and sarcomas: an immunohistochemical study of 5229 cases. Am J Surg Pathol. 2015;39:1305–12.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Oakley GJ, Fuhrer K, Seethala RR. Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis. Mod Pathol. 2008;21:1461–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Chihara C, Korogi Y, Kakeda S, Nishimura J, Murakami Y, Moriya J, Ohnari N. Ecchordosis physaliphora and its variants: proposed new classification based on high-resolution fast MR imaging employing steady-state acquisition. Eur Radiol. 2013;23:2854–60.

    Article  CAS  PubMed  Google Scholar 

  91. Krisht KM, Palmer CA, Osborn AG, Couldwell WT. Giant ecchordosis physaliphora in an adolescent girl: case report. J Neurosurg Pediatr. 2013;12:328–33.

    Article  PubMed  Google Scholar 

  92. Oh JK, Weiderpass E. Infection and cancer: global distribution and burden of diseases. Ann Glob Health. 2014;80:384–92.

    Article  PubMed  Google Scholar 

  93. Petersson F. Nasopharyngeal carcinoma: a review. Semin Diagn Pathol. 2015;32:54–73.

    Article  PubMed  Google Scholar 

  94. Ho JH. Some epidemiologic observations on cancer in Hong Kong. Natl Cancer Inst Monogr. 1979;53:35–47.

    PubMed  Google Scholar 

  95. Marks JE, Phillips JL, Menck HR. The national cancer data base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma. Cancer. 1998;83:582–8.

    Article  CAS  PubMed  Google Scholar 

  96. Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med. 1995;333:693–8.

    Article  CAS  PubMed  Google Scholar 

  97. Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol. 2002;12:431–41.

    Article  CAS  PubMed  Google Scholar 

  98. Niedobitek G, Hansmann ML, Herbst H, Young LS, Dienemann D, Hartmann CA, Finn T, Pitteroff S, Welt A, Anagnostopoulos I, et al. Epstein-Barr virus and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus. J Pathol. 1991;165:17–24.

    Article  CAS  PubMed  Google Scholar 

  99. Pathmanathan R, Prasad U, Chandrika G, Sadler R, Flynn K, Raab-Traub N. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia. Am J Pathol. 1995;146:1355–67.

    CAS  PubMed  PubMed Central  Google Scholar 

  100. Chen Y, Zhao W, Lin L, Xiao X, Zhou X, Ming H, Huang T, Liao J, Li Y, Zeng X, Huang G, Ye W, Zhang Z. Nasopharyngeal Epstein-Barr virus load: an efficient supplementary method for population-based nasopharyngeal carcinoma screening. PLoS One. 2015;10:e0132669.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  101. Sun P, Chen C, Cheng YK, Zeng ZJ, Chen XL, Liu LZ, Gu MF. Serologic biomarkers of Epstein-Barr virus correlate with TNM classification according to the seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma. Eur Arch Otorhinolaryngol. 2014;271:2545–54.

    Article  PubMed  Google Scholar 

  102. Yip TT, Ngan RK, Fong AH, Law SC. Application of circulating plasma/serum EBV DNA in the clinical management of nasopharyngeal carcinoma. Oral Oncol. 2014;50:527–38.

    Article  CAS  PubMed  Google Scholar 

  103. Chan JY, Wong ST. The role of plasma Epstein-Barr virus DNA in the management of recurrent nasopharyngeal carcinoma. Laryngoscope. 2014;124:126–30.

    Article  CAS  PubMed  Google Scholar 

  104. Tsao SW, Tsang CM, Pang PS, Zhang G, Chen H, Lo KW. The biology of EBV infection in human epithelial cells. Semin Cancer Biol. 2012;22:137–43.

    Article  CAS  PubMed  Google Scholar 

  105. Yip YL, Pang PS, Deng W, Tsang CM, Zeng M, Hau PM, Man C, Jin Y, Yuen AP, Tsao SW. Efficient immortalization of primary nasopharyngeal epithelial cells for EBV infection study. PLoS One. 2013;8:e78395.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Shao Y, Jiang H, Wu X, Luo Y, Tang W. p16 promoter hypermethylation is associated with increased risk of nasopharyngeal carcinoma. Mol Clin Oncol. 2014;2:1121–4.

    PubMed  PubMed Central  Google Scholar 

  107. Tsao SW, Tsang CM, To KF, Lo KW. The role of Epstein-Barr virus in epithelial malignancies. J Pathol. 2015;235:323–33.

    Article  CAS  PubMed  Google Scholar 

  108. Chou J, Lin YC, Kim J, You L, Xu Z, He B, Jablons DM. Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis. Head Neck. 2008;30:946–63.

    Article  PubMed  PubMed Central  Google Scholar 

  109. Hildesheim A, Wang CP. Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000–2011: Rosetta stone for NPC: genetics, viral infection, and other environmental factors. Semin Cancer Biol. 2012;22:107–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  110. Yang J, Li L, Yin X, Wu F, Shen J, Peng Y, Liu Y, Sun Y, Lu H, Zhang Y. The association between gene polymorphisms and risk of nasopharyngeal carcinoma. Med Oncol. 2015;32:398.

    Article  PubMed  CAS  Google Scholar 

  111. Fong YY, Walse EO’F. Carcinogenic nitrosamines in Cantonese salt-dried fish. Lancet. 1971;ii:1032.

    Google Scholar 

  112. Fong YY, Chan WC. Bacterial production of Di-methyl nitrosamine in salted fish. Nature. 1973;243:421–2.

    Article  CAS  PubMed  Google Scholar 

  113. Jia WH, Luo XY, Feng BJ, Ruan HL, Bei JX, Liu WS, Qin HD, Feng QS, Chen LZ, Yao SY, Zeng YX. Traditional Cantonese diet and nasopharyngeal carcinoma risk: a large-scale case–control study in Guangdong. China BMC Cancer. 2010;10:446.

    Article  PubMed  Google Scholar 

  114. Ren ZF, Liu WS, Qin HD, Xu YF, Yu DD, Feng QS, Chen LZ, Shu XO, Zeng YX, Jia WH. Effect of family history of cancers and environmental factors on risk of nasopharyngeal carcinoma in Guangdong. China Cancer Epidemiol. 2010;34:419–24.

    Article  PubMed  Google Scholar 

  115. Ward MH, Pan WH, Cheng YJ, Li FH, Brinton LA, Chen CJ, Hsu MM, Chen IH, Levine PH, Yang CS, Hildesheim A. Dietary exposure to nitrite and nitrosamines and risk of nasopharyngeal carcinoma in Taiwan. Int J Cancer. 2000;86:603–9.

    Article  CAS  PubMed  Google Scholar 

  116. Geser A, Charnay N, Day NE, de-The G, Ho HC. Environmental factors in the etiology of nasopharyngeal carcinoma: report on a case–control study in Hong Kong. IARC Sci Publ. 1978;20:213–29.

    PubMed  Google Scholar 

  117. Hildesheim A, West S, DeVeyra E, De Guzman MF, Jurado A, Jones C, Imai J, Hinuma Y. Herbal medicine use, EBV and risk of nasopharyngeal carcinoma. Cancer Res. 1992;52:3048–51.

    CAS  PubMed  Google Scholar 

  118. Clifford P, Beecher JL. Nasopharyngeal cancer in Kenya. Clinical and environmental aspects. Brit J Canc. 1964;18:25–43.

    Article  CAS  Google Scholar 

  119. Ito Y, Ohigashi H, Koshimizu K, Yi Z. Epstein-Barr virus-activating principle in the ether extracts of soils collected from under plants which contain active diterpene esters. Cancer Lett. 1983;19:113–7.

    Article  CAS  PubMed  Google Scholar 

  120. Ito Y, Tokuda H, Ohigashi H, Koshimizu K. Distribution and characterization of environmental promoter substances as assayed by synergistic Epstein-Barr virus-activating system. Princess Takamatsu Symp. 1983;14:125–37.

    CAS  PubMed  Google Scholar 

  121. Zeng Y, Miao XC, Jaio B, et al. EBV activation in Raji cells with ether extracts of soil from different areas in china. Cancer Lett. 1984;23:53–9.

    Article  CAS  PubMed  Google Scholar 

  122. Lin JH, Jiang CQ, Ho SY, Zhang WS, Mai ZM, Xu L, Lo CM, Lam TH. Smoking and nasopharyngeal carcinoma mortality: a cohort study of 101,823 adults in Guangzhou. China BMC Cancer. 2015;15:906.

    Article  PubMed  Google Scholar 

  123. Blanchard P, Lee A, Marguet S, Leclercq J, Ng WT, Ma J, Chan AT, Huang PY, Benhamou E, Zhu G, Chua DT, Chen Y, Mai HQ, Kwong DL, Cheah SL, Moon J, Tung Y, Chi KH, Fountzilas G, Zhang L, Hui EP, Lu TX, Bourhis J. Pignon JP; MAC-NPC collaborative group. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. Lancet Oncol. 2015;16:645–55.

    Article  PubMed  Google Scholar 

  124. Khedmat H, Taheri S. Post-transplantation lymphoproliferative disorders localizing in the adenotonsillar region: report from the PTLD.Int survey. Ann Transplant. 2011;16:109–16.

    Article  PubMed  Google Scholar 

  125. Akbas A, Tiede C, Lemound J, Maecker-Kolhoff B, Kreipe H, Hussein K. Post-transplant lymphoproliferative disorders with naso- and oropharyngeal manifestation. Transpl Int. 2015;28:1299–307.

    Article  PubMed  Google Scholar 

  126. Nelson BP, Wolniak KL, Evens A, Chenn A, Maddalozzo J, Proytcheva M. Early posttransplant lymphoproliferative disease: clinicopathologic features and correlation with mTOR signaling pathway activation. Am J Clin Pathol. 2012;138:568–78.

    Article  PubMed  Google Scholar 

  127. Williamson RA, Huang RY, Shapiro NL. Adenotonsillar histopathology after organ transplantation. Otolaryngol Head Neck Surg. 2001;125:231–40.

    Article  CAS  PubMed  Google Scholar 

  128. Swerdlow SH, Webber SA, Chadburn A, Ferry JA. Post-transplant lymphoproliferative disorder. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IRAC; 2008. p. 343–51.

    Google Scholar 

  129. Gheorghe G, Albano EA, Porter CC, McGavran L, Wei Q, Meltesen L, Danielson SM, Liang X. Posttransplant Hodgkin lymphoma preceded by polymorphic posttransplant lymphoproliferative disorder: report of a pediatric case and review of the literature. J Pediatr Hematol Oncol. 2007;29:112–6.

    Article  PubMed  Google Scholar 

  130. Wenig BM, Hyams VJ, Heffner DK. Nasopharyngeal papillary adenocarcinoma. A clinicopathologic study of a low-grade carcinoma. Am J Surg Pathol. 1988;12:946–53.

    Article  CAS  PubMed  Google Scholar 

  131. Carrizo F, Luna MA. Thyroid transcription factor-1 expression in thyroid-like nasopharyngeal papillary adenocarcinoma: report of 2 cases. Ann Diagn Pathol. 2005;9:189–92.

    Article  PubMed  Google Scholar 

  132. Oishi N, Kondo T, Nakazawa T, Mochizuki K, Kasai K, Inoue T, Yamamoto T, Watanabe H, Hatsushika K, Masuyama K, Katoh R. Thyroid-like low-grade nasopharyngeal papillary adenocarcinoma: case report and literature review. Pathol Res Pract. 2014;210:1142–5.

    Article  PubMed  Google Scholar 

  133. Wu PY, Huang CC, Chen HK, Chien CY. Adult thyroid-like low-grade nasopharyngeal papillary adenocarcinoma with thyroid transcription factor-1 expression. Otolaryngol Head Neck Surg. 2007;137:837–8.

    Article  PubMed  Google Scholar 

  134. Ohe C, Sakaida N, Tadokoro C, Fukui H, Asako M, Tomoda K, Uemura Y. Thyroid-like low-grade nasopharyngeal papillary adenocarcinoma: report of two cases. Pathol Int. 2010;60:107–11.

    Article  PubMed  Google Scholar 

  135. Fu CH, Chang KP, Ueng SH, Wu CC, Hao SP. Primary thyroid-like papillary adenocarcinoma of the nasopharynx. Auris Nasus Larynx. 2008. doi:10.1016/j.anl.2007.10.009.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Appendices

Self Study

  1. 1.

    Which statement regarding Fig. 5.27 is most likely to be correct?

    Fig. 5.27
    figure 27

    Self study

    1. (a)

      This is a nasopharyngeal biopsy from a young Chinese American woman. Skullbase CT and MR should be performed.

    2. (b)

      This is a nasopharyngeal biopsy from a young American Caucasian woman, status post lung transplant for cystic fibrosis. The next step would involve decreasing her immunosuppression.

    3. (c)

      This is a nasopharyngeal biopsy from a 15-year old African American male with obstructive sleep apnea.

    4. (d)

      This is a nasopharyngeal biopsy from a 15-year old Caucasian American female recently diagnosed with classical Hodgkin’s disease. Where is Thomas Hodgkin buried?

  2. 2.

    Which statement regarding Fig. 5.28 is most likely to be correct?

    Fig. 5.28
    figure 28

    Self study

    1. (a)

      This is a nasopharyngeal biopsy from a 15-year old Caucasian American male; IHC is for TTF-1.

    2. (b)

      This is a nasopharyngeal biopsy from a 15-year old male who complained of epistaxis and nasal obstruction. Holman-Miller sign is present radiographically.

    3. (c)

      This is a nasopharyngeal biopsy from a 50-year old male Caucasian American carpenter; serum EBV DNA is elevated.

    4. (d)

      This is a nasopharyngeal biopsy from a 70-year old Chinese male; IHC is for Cam 5.2

  3. 3.

    Which statement regarding Fig. 5.29 is most likely to be correct?

    Fig. 5.29
    figure 29

    Self study

    1. (a)

      CTNNB1 mutation and aberrant β-catenin expression are common.

    2. (b)

      “Wet keratin” and calcifications distinguished one variant, which commonly harbor the BRAF V600E mutation.

    3. (c)

      This tumor arises from Tornwaldt’s bursa.

    4. (d)

      Standard of care consists of primary radiotherapy.

Answers

  1. 1.

    Which statement regarding Fig. 5.27 is most likely to be correct?

    This is a nonkeratinizing nasopharyngeal carcinoma (NK-NPC) (left). The right image is of ISH for EBER.

    1. (a)

      This is a nasopharyngeal biopsy from a young Chinese American woman. Skullbase CT and MR should be performed. Yes. The carcinoma cells (left) have an immunoblast-like appearance. The relatively sharp demarcation from adjacent lymphocytes, on light microscopy and EBER ISH (right) speaks for their epithelial origin. The incidence of NPC in first generation Chinese Americans is less than in endemic regions, yet higher than Caucasian Americans.

    2. (b)

      This is a nasopharyngeal biopsy from a young American Caucasian woman, status post lung transplant for cystic fibrosis. The next step would involve decreasing her immunosuppression. No – A lymphoproliferative process is ruled out by the above features.

    3. (c)

      This is a nasopharyngeal biopsy from a 15-year old African American male with obstructive sleep apnea. No – Normal adenoidal crypt epithelial cells have smaller nuclei and are more mature. Any EBER signals, if present, would be confined to a few lymphocytes.

    4. (d)

      This is a nasopharyngeal biopsy from a 15-year old Caucasian American female recently diagnosed with classical Hodgkin’s disease. Where is Thomas Hodgkin buried? Thomas Hodgkin, a pre-eminent pathologist, was also the personal physician of Sir Moses Montefiore. He died of dysentery while accompanying Montefiore on one of his many trips to Israel, and is buried in Jaffa.

  2. 2.

    Which statement regarding Fig. 5.28 is most likely to be correct?

    This is another NK-NPC, and the IHC is for keratin.

    1. (a)

      This is a nasopharyngeal biopsy from a 15-year old Caucasian American male; IHC is for TTF-1. No–Thyroid-like low-grade nasopharyngeal papillary adenocarcinoma form predominantly exophytic tumors. TTF-1 will be expressed in nuclei; you might be able to appreciate that this image demonstrates cytoplasmic staining.

    2. (b)

      This is a nasopharyngeal biopsy from a 15-year old male who complained of epistaxis and nasal obstruction. Holman-Miller sign is present radiographically. No – The Holman-Miller sign (bowing of the posterior antral wall anteriorly) is pathogneumonic for nasopharyngeal angiofibroma.

    3. (c)

      This is a nasopharyngeal biopsy from a 50-year old male Caucasian American carpenter; serum EBV DNA is elevated. No – NPC in US Caucasians is more likely to be keratinizing and unrelated to EBV.

    4. (d)

      This is a nasopharyngeal biopsy from a 70-year old Chinese male; IHC is for Cam 5.2.–Yes

  3. 3.

    Which statement regarding Fig. 5.29 is most likely to be correct?

     This is an adamantinomatous craniopharyngioma, which is usually associated aberrant activation of the WNT/β-catenin pathway

    1. (a)

      CTNNB1 mutation and aberrant β-catenin expression are common. Yes

    2. (b)

      “Wet keratin” and calcifications distinguished one variant, which commonly harbor the BRAF V600E mutation. No. Wet keratin” and calcifications distinguish the adamantinomatous variant from the papillary variant; the latter commonly harbors the BRAF V600E mutation.

    3. (c)

      This tumor arises from Tornwaldt’s bursa. No. It arises along the migrational path of Rathke’s pouch.

    4. (d)

      Standard of care consists of primary radiotherapy. No. Adamantinomatous craniopharyngioma is associated with a significant rate of local recurrence. Standard of care is primary surgery (either endoscopic endonasal or stereotactic microscopic) with adjuvant radiotherapy for inadequate resections.

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Brandwein, M.S. (2016). Nasopharynx and Skull Base. In: Textbook of Head and Neck Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-33323-6_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-33323-6_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-33321-2

  • Online ISBN: 978-3-319-33323-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics